REQUEST A DEMO
Total
USD $0.00
Search more companies

Institute Europharm, S.R.O. (Slovakia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Institute Europharm, S.R.O. Profile Updated: October 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Institute Europharm, S.R.O. is based in Slovakia, with the head office in Kezmarok. It operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on July 20, 2007. It currently has a total number of 20 - 24 (2023) employees. In 2023, the company reported a net sales revenue increase of 30.87%. Over the same period, its total assets grew by 1.12%. The net profit margin of Institute Europharm, S.R.O. increased by 42.1% in 2023.

Headquarters
Weinova, 3
Kezmarok; Presovsky; Postal Code: 06001

Contact Details: Purchase the Institute Europharm, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Institute Europharm, S.R.O. report to view the information.
Outstanding Shares:
Purchase the Institute Europharm, S.R.O. report to view the information.
Registered Capital:
Purchase the Institute Europharm, S.R.O. report to view the information.
Incorporation Date:
July 20, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
15%
Purchase this report to view the information.
14.5%
Purchase this report to view the information.
14%
Purchase this report to view the information.
14%
Purchase this report to view the information.
11.5%
Company Performance
Financial values in the chart are available after Institute Europharm, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
30.87%
Total operating revenue
32.47%
Operating profit (EBIT)
25.9%
EBITDA
69.74%
Net Profit (Loss) for the Period
26.67%
Total assets
1.12%
Total equity
7.99%
Operating Profit Margin (ROS)
42.72%
Net Profit Margin
42.1%
Return on Equity (ROE)
27.16%
Debt to Equity Ratio
-47.86%
Quick Ratio
0.25%
Cash Ratio
0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?